Jiandong Xu

Insider Reports History

Location
New York, NY
Signature
/s/ Jiandong Xu
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jiandong Xu:

Company Role Class Num Shares Value Price $ Report Date Ownership
Denali Capital Acquisition Corp. 10%+ Owner Class B Ordinary Shares 1,432,500 30 Aug 2024 Indirect
Estrella Immunopharma, Inc. Chief Financial Officer Nonstatutory Share Option 509,203 30 Oct 2024 Direct
Estrella Immunopharma, Inc. Chief Financial Officer Incentive Share Option 490,796 30 Oct 2024 Direct

Insider Reports Filed by Jiandong Xu

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ESLA Estrella Immunopharma, Inc. 30 Oct 2024 2 $0 4 Chief Financial Officer 14 Feb 2025, 16:30
DNQAF Denali Capital Acquisition Corp. 30 Aug 2024 1 $0 4 10%+ Owner 16 Sep 2024, 10:01
ESLA Estrella Immunopharma, Inc. 29 Sep 2023 0 $0 3 Chief Financial Officer 10 Oct 2023, 16:18
DNQAF Denali Capital Acquisition Corp. 21 May 2022 1 $0 4 10%+ Owner 24 May 2022, 16:20
DNQAF Denali Capital Acquisition Corp. 11 Apr 2022 1 +$5,100,000 4 10%+ Owner 13 Apr 2022, 16:51
DNQAF Denali Capital Acquisition Corp. 06 Apr 2022 0 $0 3 10%+ Owner 06 Apr 2022, 20:45